Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes 55:1713-1722, 2006
DOI: 10.2337/db05-1513
© 2006 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sagen, J. V.
Right arrow Articles by Matschinsky, F. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sagen, J. V.
Right arrow Articles by Matschinsky, F. M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

From Clinicogenetic Studies of Maturity-Onset Diabetes of the Young to Unraveling Complex Mechanisms of Glucokinase Regulation

Jørn V. Sagen1, Stella Odili2, Lise Bjørkhaug1,3, Dorothy Zelent2, Carol Buettger2, Jae Kwagh4, Charles Stanley4, Knut Dahl-Jørgensen5, Carine de Beaufort6, Graeme I. Bell7, Yi Han8, Joseph Grimsby8, Rebecca Taub8, Anders Molven9, Oddmund Søvik1, Pål R. Njølstad1,3,10, and Franz M. Matschinsky2

1 Section for Pediatrics, Department of Clinical Medicine, University of Bergen, Bergen, Norway
2 Department of Biochemistry and Biophysics and Diabetes Research Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
3 Section for Medical Genetics and Molecular Medicine, Department of Clinical Medicine, University of Bergen, Bergen, Norway
4 Division of Endocrinology, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
5 Department of Pediatrics, Ullevål University Hospital, Oslo, Norway
6 Pediatric Department, Centre Hospitalier de Luxembourg, Luxembourg
7 Departments of Medicine and Human Genetics, University of Chicago, Chicago, Illinois
8 Department of Metabolic Diseases, Hoffmann-La Roche, Nutley, New Jersey
9 Section for Pathology, The Gade Institute, University of Bergen, Bergen, Norway
10 Department of Pediatrics, Haukeland University Hospital, Bergen, Norway

Address correspondence and reprint requests to Dr. Pål R. Njølstad, Section for Pediatrics, Department of Clinical Medicine, University of Bergen, Haukeland University Hospital, N-5021 Bergen, Norway. E-mail: pal.njolstad{at}uib.no

Abbreviations: GKA, glucokinase activator; GKRP, glucokinase regulatory protein; GSIR, glucose-stimulated insulin release; GST, glutathionyl S-transferase; MODY2, maturity-onset diabetes of the young, type 2; PEOE, partial equalization of orbital electronegativities; PNDM, permanent neonatal diabetes mellitus

Glucokinase functions as a glucose sensor in pancreatic ß-cells and regulates hepatic glucose metabolism. A total of 83 probands were referred for a diagnostic screening of mutations in the glucokinase (GCK) gene. We found 11 different mutations (V62A, G72R, L146R, A208T, M210K, Y215X, S263P, E339G, R377C, S453L, and IVS5 + 1G>C) in 14 probands. Functional characterization of recombinant glutathionyl S-transferase–G72R glucokinase showed slightly increased activity, whereas S263P and G264S had near-normal activity. The other point mutations were inactivating. S263P showed marked thermal instability, whereas the stability of G72R and G264S differed only slightly from that of wild type. G72R and M210K did not respond to an allosteric glucokinase activator (GKA) or the hepatic glucokinase regulatory protein (GKRP). Mutation analysis of the role of glycine at position 72 by substituting E, F, K, M, S, or Q showed that G is unique since all these mutants had very low or no activity and were refractory to GKRP and GKA. Structural analysis provided plausible explanations for the drug resistance of G72R and M210K. Our study provides further evidence that protein instability in combination with loss of control by a putative endogenous activator and GKRP could be involved in the development of hyperglycemia in maturity-onset diabetes of the young, type 2. Furthermore, based on data obtained on G264S, we propose that other and still unknown mechanisms participate in the regulation of glucokinase.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
L. Bjorkhaug, J. Molnes, O. Sovik, P. R. Njolstad, and T. Flatmark
Allosteric Activation of Human Glucokinase by Free Polyubiquitin Chains and Its Ubiquitin-dependent Cotranslational Proteasomal Degradation
J. Biol. Chem., August 3, 2007; 282(31): 22757 - 22764.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. Arden, A. Trainer, N. de la Iglesia, K. T. Scougall, A. L. Gloyn, A. J. Lange, J. A.M. Shaw, F. M. Matschinsky, and L. Agius
Cell Biology Assessment of Glucokinase Mutations V62M and G72R in Pancreatic {beta}-Cells: Evidence for Cellular Instability of Catalytic Activity
Diabetes, July 1, 2007; 56(7): 1773 - 1782.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. F. Pino, K.-A. Kim, K. D. Shelton, J. Lindner, S. Odili, C. Li, H. W. Collins, M. Shiota, F. M. Matschinsky, and M. A. Magnuson
Glucokinase Thermolability and Hepatic Regulatory Protein Binding Are Essential Factors for Predicting the Blood Glucose Phenotype of Missense Mutations
J. Biol. Chem., May 4, 2007; 282(18): 13906 - 13916.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2006 by the American Diabetes Association.